Masahito Shimojo
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 15, 2024
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides.Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori
|Jan 17, 2023
An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells.Misa Yoshida, Chihiro Oda, Keishiro Mishima
|May 22, 2019
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.Masahito Shimojo, Yuuya Kasahara, Masaki Inoue
Pageof 1
